CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Condensed Consolidated Statements Of Operations
Revenue	$ 42,000
Operating costs:
General and administrative expenses	776,000	813,000
Research and development	824,000	962,000
Total operating costs and expenses	1,600,000	1,775,000
Operating loss	(1,558,000)	(1,775,000)
Other income and (expenses):
Interest and other expenses	(96,000)	(121,000)
NET (LOSS) INCLUDING NONCONTROLLING INTEREST	(1,654,000)	(1,896,000)
Net (loss) attributable to noncontrolling interest	(472,000)
NET (LOSS) ATTRIBUTABLE TO MANHATTAN SCIENTIFICS, INC.	$ (1,182,000)	$ (1,896,000)
BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE:
Weighted average number of common shares outstanding (Basic)	533,781,064	537,398,549
Basic loss per common share	$ .00	$ .00
Weighted average number of common shares outstanding (Diluted)	533,781,064	537,398,549
Diluted loss per common share	$ .00	$ .00